JUVÉDERM VOLLURE™ XC

Juvederm Vollure xc

JUVÉDERM VOLLURE™ injectable gel adds volume to correct moderate to severe facial wrinkles and laugh lines.

Looking for a longer term solution which will smooth parentheses lines and wrinkles? Perhaps with age you’ve noticed laugh or smile lines around your nose and mouth due to a loss of skin elasticity? JUVÉDERM VOLLURE XC can help. This dermal filler is specifically designed to address facial wrinkles around the mouth and lower face.

Cost

Juvederm Vollure Logo
JUVÉDERM VOLLURE™ XC

What is JUVÉDERM VOLLURE XC?

JUVÉDERM VOLLURE XC is the newly FDA approved injectable filler designed to add volume beneath the nasolabial folds, or laugh lines. It uses Vycross technology to lift and contour these facial wrinkles and folds. This creates a more connected gel that’s firm enough to fill and soft enough for natural movement. The result is a more youthful appearance. It is more natural-looking and lasts a full year longer than other dermal fillers on the market.

Individual results may vary.

How JUVÉDERM VOLLURE™ XC works

JUVÉDERM VOLLURE™ XC contains hyaluronic acid gel. This is compatible with the body, because hyaluronic acid is found in almost every single living thing. Therefore, the risk for any severe allergic reaction to the injection is very low. Hyaluronic acid (HA) acts like an inflated cushion that supports facial structures and tissues that have lost volume or elasticity in the aging process. In addition, HA brings water to the surface layers of skin, making it appear fresh and more supple.

What we love about it

This is the longest lasting hyaluronic acid filler in its category. It’s also immediate and reversible. Even more importantly, it allows changes in the contours of the face. Plus, JUVÉDERM VOLLURE™ XC lasts up to 18 months. The new formula produces minimal swelling, which means shorter recovery time and less discomfort. It adds subtle volume and can last 3 times as long as comparable products. It’s a great choice for men and women alike.

What to expect

Before beginning treatment, we will examine the nasolabial area to determine if JUVÉDERM VOLLURE™ XC is right for you. Then we will tailor a treatment designed for your aesthetic goals. One treatment is complete in 15-20 minutes. You will likely experience some tenderness, swelling, bruising, or itching for up to 2 weeks.

How many treatments?

One treatment and a possible touch-up lasts up to 18 months.

Target Area

target-area-juvederm-vollure-female
target-area-juvederm-volbella-lips-male

Possible side effects

The most common side effects include tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Most side effects were mild or moderate and lasted 14 days or less. One of the risks with using this product is unintentional injection into a blood vessel. While rare, it can cause serious complications. These include vision abnormalities, blindness, stroke, temporary scabs, or scarring. As with all skin injection procedures, there is a risk of infection.

What others are saying

“I love to laugh but it was starting to show in my face and age my appearance. The simple smoothness makes me look and feel younger. The treatment was quick and easy and I’m thrilled at the expectation that this can last 18 months without another treatment.”

Questions and Answers

The only filler proven to last up to 18 months in clinical trials for nasolabial folds and wrinkles.* These are among the most common signs of aging that patients wish to address as they get older.

*With optimal treatment. Results may vary.

See the “after” photos for the dramatic lift and contour results. If your face has lost its fullness, JUVÉDERM VOLLURE™ XC might be right for you.
JUVÉDERM VOLLURE™ XC was officially approved by the FDA in the March, 2017. It was approved in Europe in 2013 (under the name Juvéderm Volift)

JUVEDERM VOLLURE Before and After

Individual results may vary

Juvederm Vollure-before
vollure-after
Schedule A Consultation With Dr. Kay!
  • This field is for validation purposes and should be left unchanged.